We are seeking to maximize the potential of our novel respiratory EP-101 Phase 2b clinical program and bring our promising therapy to COPD patients as quickly and efficiently as possible. Elevation Pharmaceuticals is seeking regional or global life science partners to facilitate the late-stage development and commercialization of our products. We welcome requests from interested companies wishing to discuss partnering opportunities with us. Please contact us at:
The Freedom to Breathe Easier